Return to Trial Database

GU10-147

Phase II Trial of Everolimus or Everolimus Plus Paclitaxel as First-line Therapy in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma: Hoosier Cancer Research Network GU10-147.

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial GU10-147 being conducted in.

No data was found